Innovation, Commercialization, and Start-Ups in Life Sciences

James F. Jordan

$189

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press Inc
05 November 2014

Entrepreneurship; Biotechnology industries

Innovation is the translation of a new method, idea, or product into reality and profit. It is a process of connected steps that accumulates into your brand or reputation. However, there can be many pitfalls and wrong turns on the road to realizing this goal. Innovation, Commercialization, and Start-Ups in Life Sciences details the methodologies necessary to create a successful life sciences start-up from initiation to exit. You will gain an appreciation for the necessary data, partnership, and skills to be acquired and the constituencies that must be satisfied along the way.

The book examines how life sciences start-ups can create an exit for their investors by recognizing that a liquidity event is not consummated without due diligence. Due diligence is bigger than validating accounting transactions. It ensures the company is solving an important customer problem, demonstrating sales access, and making sure that intellectual property is impervious to competitive advancement. The due diligence process supports the telling of a compelling story to customers, investors, regulators, and acquirers.

Written by an expert who has worked with more than 200 life sciences start-ups during the past decade, the book discusses specific processes and investor milestones that must be navigated to align customer, funder, and acquirer needs. It examines these processes from the perspective of marketing value through a focus on the needs of individual constituents—investors, regulators, customers, and exit candidates. The book presents data and analytical processes articulating the fundable milestones for angel and venture capital. It gives you the tools needed to create branding for public investors and more.

By: James F. Jordan
Imprint: CRC Press Inc
Country of Publication: United States
Dimensions: Height: 234mm, Width: 156mm, Spine: 18mm
Weight: 521g
ISBN: 9781482210125
ISBN 10: 1482210126
Pages: 234
Publication Date: 05 November 2014
Audience: Professional and scholarly , College/higher education , Undergraduate , Primary
Replaced By: 9780367533038
Format: Hardback
Publisher's Status: Active

Part 1 – Innovation is a Process of Connected Steps. Investment Uses a Translation Process to Deliver Innovation. Investment is Critical to a Nation’s Prosperity. The Journey of Innovation Begins With Investment. The U.S. Helps Small Companies Develop Technology. Commercialization is Primarily Executed Through Two Organizational Types. Part 2 – Investment Must Be Connected to Exit. Angels and Venture Capitalists Invest in Commercialization. Create Liquidity For Your Investors. A Liquidity Event is Not Consummated Without Due Diligence. Due Diligence Reputation is a Critical Business Process. Part 3 – Align With the Industry Norms. Find the Industry Norms. Solve an Important Customer Problem. Demonstrate the Ability to Access the Sales Channel. Gather Domain-Experienced Personnel to Reduce Risk. Determine Acquirers’ Strategic Future and Purchase Triggers. Align Investor’s Fundable Milestones and Acquirer’s Exit Points. Create an IP Pyramid for Impervious Positioning. Part 4 – A Startup Must Tell a Compelling Story. Address Your Story to the Needs of All Constituencies. Deliver to Your Plan. Tell a Compelling Story With the Investor Pitch. Continuously Improve Your Message With the Plan-Do-Check-Act Cycle.

Jim Jordan, a Distinguished Service Professor of Healthcare & Biotechnology Management and Senior Director of Healthcare and Biotechnology Programs at Carnegie Mellon University’s Heinz College, serves as the Chief Investment Officer of the Pittsburgh Life Sciences Greenhouse, a public-private economic and venture fund owned by Carnegie Mellon University and the University of Pittsburgh. As an accomplished Fortune 20-level executive with companies such as Boston Scientific, Johnson & Johnson and McKesson, Jim has leveraged his experience in several startup ventures and is active on multiple Boards of Directors. Through the Pittsburgh Life Sciences Greenhouse, he has applied his 25 years of experience in industry, consulting and academia to work with over 400 life science startup companies, with direct investment in 75 of them.

Reviews for Innovation, Commercialization, and Start-Ups in Life Sciences

""So how do you get more new innovative technology to market? Well, you take risks for sure, but you have to have a process for churning the evolution of technology and turning concepts in the minds of researchers and entrepreneurs into commercialized products in the market. The contents of this book will not only do that for the reader, but the book will also show the pitfalls to avoid along the way. Not every good idea is able to get to market. … And what causes innovators to fail? The answers to these and other important questions are addressed in the book."" —From the Foreword by John W. Manzetti, President and CEO, Pittsburgh Life Sciences Greenhouse, Founder, Managing Director, PLSG Accelerator Fund ""This book, and the approach the author describes in it, is based in extensive real-life experience. The author gives the reader the theory behind innovation and commercialization, but then adds the application details only an experienced professional can deliver. ... I like the fact that the book is driven from the perspective of the investor versus the technologist or policy analyst. ... I think the author has written a very useful guide that is clear and compelling."" —William Donaldson, Christopher Newport University, Newport News, Virginia, USA